Stereotaxis has announced that it will present at the 29th Annual Meeting of the Japanese Heart Rhythm Society in Tokyo beginning July 23, 2014. The three-day event is the first large-scale opportunity for the company’s in-country distributors, Medix Japan and Hokushin Medical to promote the clinical value of the Stereotaxis Niobe magnetic navigation system for cardiac ablations to the Japan electrophysiology market. Stereotaxis entered into an agreement with the two medical device distributors in February 2014 to market, sell and distribute the Niobe system and disposable devices to Japanese customers.
Medix Japan and Hokushin Medical have been in active dialogue with electrophysiology physicians on behalf of Stereotaxis. In conjunction with the commercialisation efforts, the companies have been meeting with prestigious medical centres on the potential for research collaboration and preparing the necessary filings for regulatory approval of Stereotaxis’ Vdrive robotic navigation system and Odyssey information management solution product lines.
“We are very pleased with the level of commitment this team has demonstrated in bringing awareness of our technology to a high priority market, and we look forward to engaging with the Japanese EP community at Japan HRS,” says William C Mills, Stereotaxis chief executive officer.
In addition to exhibiting at the event, the company will be featured during a one-hour panel discussion on 25 July, “Current Status and Future of Robotic Catheter Mapping and Ablation,” presented by Hiroshi Nakagawa (University of Oklahoma Health Sciences Center) and moderated by Kenzo Hirao (Tokyo Medical and Dental University).
